Multidisciplinary Approach to Reduce Injury and Substance Abuse
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The primary purpose of the project entitled: Multidisciplinary Approach to Reduce Injury and Substance Abuse, which is funded by the National Institute on Drug Abuse (5R01DA026088-02), is to compare the effectiveness of brief intervention, brief intervention plus a booster, and brief advice for adult patients who abuse drugs and present to a trauma department for treatment of an injury.
| Condition | Intervention | Phase |
|---|---|---|
|
Drug Abuse Among Patients Admitted to a Trauma Department. |
Behavioral: Brief advice Behavioral: Brief Intervention plus Booster Session (BMI+B) Behavioral: Brief Intervention |
Phase 3 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Outcomes Assessor) Primary Purpose: Prevention |
| Official Title: | Multidisciplinary Approach to Reduce Injury and Substance Abuse |
- The primary outcome of interest will be patients' subsequent drug use. [ Time Frame: 3, 6, and 12 months after intervention ] [ Designated as safety issue: No ]
- HIV risk-behaviors, improved health, increased employment, decreased illegal behavior, increased substance treatment, enhanced quality of life, use of Transtheoretical model of change, organization implementation, and intervention cost-effectiveness. [ Time Frame: 3, 6, and 12 months after intervention ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 930 |
| Study Start Date: | January 2010 |
| Estimated Study Completion Date: | September 2013 |
| Estimated Primary Completion Date: | September 2012 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Experimental: Brief Intervention |
Behavioral: Brief Intervention
A brief drug use intervention based on motivational interviewing is provided to participants at baseline
|
|
Active Comparator: Brief advice
This condition of the experiment acts a control and will be a short session in which the therapist will provide brief advice about drug use and give the patient a pamphlet.
|
Behavioral: Brief advice
The American College of Surgeons (ACS) recently mandated standards of care for all level I trauma centers and currently defined standards of care at the collaborating institution requires that assessment and referral are included in treatment as usual. Therefore, our treatment as usual, or BA, consists of an initial interview conducted by study staff, a recommendation to abstain from drug use, provision of educational material supporting that recommendation, referral to hospital or community treatment resources most likely to be beneficial to the patient and information about relevant community health care agencies.
|
| Experimental: Brief Intervention plus Booster |
Behavioral: Brief Intervention plus Booster Session (BMI+B)
A brief drug use intervention based on motivational interviewing is provided to participants at baseline and a booster session incorporating personalized feedback is provided at one month
|
Detailed Description:
Multidisciplinary Approach to Reduce Injury and Substance Abuse is a randomized clinical trial evaluating the effectiveness of brief advice (BA), brief motivational intervention with feedback (BMI), and brief motivational intervention with feedback and booster (BMI+B) in injured patients with drug problems.
The setting is UMC Brackenridge Hospital Trauma Department, which serves a large and diverse patient population. Injured patients are screened for eligibility in the project based on a positive tox screen or self reported drug use in the past 90 days. The primary outcome of interest will be patients' subsequent drug use. Other outcomes of interest include: HIV-related risk behaviors, improved health outcomes (including injury reduction), increased employment, decreased engagement in illegal behavior, increased substance abuse treatment utilization, and enhanced quality of life at three, six, and twelve month follow-ups.
This study will also examine the potential moderating and mediating effects of patient readiness to change, use of experiential and behavioral processes of change and decisional balance considerations. In addition, this project will examine implementation factors at the organizational level and the cost effectiveness of BA, BMI, and BMI+B.
Study participants and their related identifying information will be collected during the time they are admitted to the UMC Brackenridge Hospital Trauma Department. Study participants must be 18 years or older, speak English or Spanish, have been admitted to the UMC Brackenridge Hospital Trauma Department, and test positive for illegal drugs or admit to illegal drug use when verbally screened. Additional information will be collected from participants in appointments at UMC Brackenridge at three, six, and 12 month follow-up periods.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Study participants must be 18 years or older
- Speak English or Spanish
- Been admitted to the UMC Brackenridge Hospital Trauma Department
- Test positive for illegal drugs or admit to illegal drug use
Exclusion Criteria:
- Other penetrating trauma not related to motor vehicle collisions, violence or falls, such as poisoning and, bites
- Patients with traumatic brain injury, or a Glasgow Coma Scalescore of less than 15
- Patients who do not pass the Mini-Mental Status Exam are excluded
Contacts and Locations| Contact: Mary M Velasquez, PhD | (512) 471-7019 | velasquez@austin.utexas.edu |
| Contact: Craig A Field, PhD | (512) 232-0624 | craig.field@austin.utexas.edu |
| United States, Texas | |
| University Medical Center Brackenridge | Recruiting |
| Austin, Texas, United States, 78701 | |
| Contact: Craig A Field, PhD 512-324-8470 craig.field@austin.utexas.edu | |
| Contact: Gerald T Cochran, MSW (512) 232-0637 jcochran@mail.utexas.edu | |
| Principal Investigator: Craig A Field, PhD | |
| Principal Investigator: | Mary M Velasquez, PhD | University of Texas at Austin |
| Principal Investigator: | Craig A Field, PhD | University of Texas at Austin |
More Information
No publications provided
| Responsible Party: | University of Texas at Austin |
| ClinicalTrials.gov Identifier: | NCT01048359 History of Changes |
| Other Study ID Numbers: | DESPR DA026088, 5R01DA026088-02 |
| Study First Received: | January 11, 2010 |
| Last Updated: | May 4, 2012 |
| Health Authority: | United States: Federal Government |
Keywords provided by University of Texas at Austin:
|
Drug abuse, substance abuse, injury, trauma, and screening and brief intervention. |
Additional relevant MeSH terms:
|
Substance-Related Disorders Mental Disorders |
ClinicalTrials.gov processed this record on May 23, 2013